Benefit category designation and payment determination expands patient access to the only FDA-cleared non-invasive targeted therapy for hand tremorSAN MATEO, Calif. (BUSINESS WIRE) Cala, the bioelectronic medicine leader setting a new standard of patient care for chronic disease, today announced that the Centers f.
/PRNewswire/ NeuroDerm Ltd., a wholly owned subsidiary of Mitsubishi Tanabe Pharma Corporation, announced positive, long-term safety and tolerability data.